BackPrelude Therapeutics Overview
Prelude Therapeutics Inc

Prelude Therapeutics Target Price

Analysts' 12-month price predictions for PRLD.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.66

Average Target Price

$8.00118.6% upside

1 analysts in the last 4 months

High: $8 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-27H.C. Wainwright$8118.6% upsideOpen
2024-09-10H.C. WainwrightRobert Burns$536.6% upsideOpen
2024-06-20BarclaysPeter Lawson$318% downsideOpen
2024-03-13JMP SecuritiesReni Benjamin$791.3% upsideOpen
2022-11-17H.C. Wainwright$15309.8% upsideOpen
2022-11-15Morgan Stanley$10173.2% upsideOpen